TCI Wealth Advisors’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,732
| Closed | -$111K | – | 380 |
|
|
2023
Q1 | $111K | Hold |
3,732
| – | – | 0.01% | 265 |
|
|
2022
Q4 | $101K | Buy |
3,732
+246
| +7% | +$6.01K | 0.01% | 263 |
|
|
2022
Q3 | $76K | Sell |
3,486
-158
| -4% | -$4.13K | 0.01% | 283 |
|
|
2022
Q2 | $100K | Sell |
3,644
-100
| -3% | -$2.87K | 0.02% | 250 |
|
|
2022
Q1 | $126K | Buy |
3,744
+122
| +3% | +$3.93K | 0.02% | 226 |
|
|
2021
Q4 | $126K | Sell |
3,622
-105
| -3% | -$3.4K | 0.02% | 231 |
|
|
2021
Q3 | $116K | Buy |
3,727
+171
| +5% | +$5.8K | 0.02% | 260 |
|
|
2021
Q2 | $129K | Buy |
3,556
+31
| +0.9% | +$1.28K | 0.02% | 238 |
|
|
2021
Q1 | $154K | Buy |
3,525
+41
| +1% | +$1.92K | 0.07% | 186 |
|
|
2020
Q4 | $160K | Hold |
3,484
| – | – | 0.07% | 181 |
|
|
2020
Q3 | $116K | Hold |
3,484
| – | – | 0.05% | 194 |
|
|
2020
Q2 | $102K | Hold |
3,484
| – | – | 0.04% | 206 |
|
|
2020
Q1 | $94K | Buy |
3,484
+353
| +11% | +$10.5K | 0.05% | 209 |
|
|
2019
Q4 | $106K | Hold |
3,131
| – | – | 0.04% | 250 |
|
|
2019
Q3 | $117K | Sell |
3,131
-5
| -0.2% | -$191 | 0.05% | 191 |
|
|
2019
Q2 | $137K | Hold |
3,136
| – | – | 0.06% | 176 |
|
|
2019
Q1 | $134K | Hold |
3,136
| – | – | 0.06% | 190 |
|
|
2018
Q4 | $140K | Sell |
3,136
-53
| -2% | -$2.78K | 0.07% | 178 |
|
|
2018
Q3 | $218K | Buy |
+3,189
| New | +$205K | 0.09% | 142 |
|
|
2018
Q2 | – | Sell |
-3,215
| Closed | -$148K | – | 1502 |
|
|
2018
Q1 | $148K | Hold |
3,215
| – | – | 0.07% | 170 |
|
|
2017
Q4 | $148K | Buy |
3,215
+31
| +1% | +$1.43K | 0.07% | 187 |
|
|
2017
Q3 | $143K | Hold |
3,184
| – | – | 0.07% | 171 |
|
|
2017
Q2 | $125K | Hold |
3,184
| – | – | 0.06% | 180 |
|
|
2017
Q1 | $121K | Hold |
3,184
| – | – | 0.06% | 194 |
|
|
2016
Q4 | $118K | Hold |
3,184
| – | – | 0.06% | 207 |
|
|
2016
Q3 | $110K | Hold |
3,184
| – | – | 0.06% | 199 |
|
|
2016
Q2 | $104K | Hold |
3,184
| – | – | 0.06% | 199 |
|
|
2016
Q1 | $91K | Hold |
3,184
| – | – | 0.05% | 218 |
|
|
2015
Q4 | $106K | Sell |
3,184
-54
| -2% | -$1.68K | 0.06% | 203 |
|
|
2015
Q3 | $92K | Buy |
3,238
+54
| +2% | +$1.88K | 0.06% | 203 |
|
|
2015
Q2 | $129K | Sell |
3,184
-11
| -0.3% | -$494 | 0.07% | 172 |
|
|
2015
Q1 | $157K | Hold |
3,195
| – | – | 0.1% | 134 |
|
|
2014
Q4 | $145K | Buy |
+3,195
| New | +$126K | 0.09% | 146 |
|
Other funds holding AVNS
RC
PIM
WHG
TCI Wealth Advisors's AVNS Position: Q2 2023 in Review
TCI Wealth Advisors sold out of Avanos Medical (AVNS) in Q2 2023, closing a stake of 3,732 shares — an estimated $111K sold.
TCI Wealth Advisors first reported a position in AVNS in Q4 2014 and held it in 33 quarters. The position peaked at $218K in Q3 2018. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2023.
- TCI Wealth Advisors reported no remaining Avanos Medical position as of Q2 2023 after selling out during the quarter.
- TCI Wealth Advisors sold 3,732 Avanos Medical shares in Q2 2023, an estimated $111K.
- TCI Wealth Advisors first reported a position in Avanos Medical in Q4 2014 and held it in 33 quarters.
- TCI Wealth Advisors's Avanos Medical position peaked at $218K in Q3 2018.
- 274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2023.
Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.